Tuesday, June 21, 2016

BRIEF-Biostage CEO provides mid-year update to shareholders

* Now have capital to get through a number of milestones in

2016 including filing of IND; expect to move into human clinical

trials in 2017

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)